In This Section      

Johns Hopkins Gynecology - From the Director

Winter 2015

From the Director

Date: January 13, 2015

Andrew Satin, M.D.
Andrew Satin, M.D., Director, Johns Hopkins Department of Gynecology and Obstetrics

Dear Colleague,

I continue to be amazed at the dedication and ingenuity of our gynecology team. Daily, I see members of our team providing outstanding care and saving lives, from the tiny fetus to the postmenopausal patient with a cancer diagnosis. We continually explore new therapies and expand our services to enhance outcomes and shorten recoveries for our patients.

Breathtaking in utero images now provide physicians in our new Center for Fetal Therapy with the ability to diagnose fetal anomalies, and in many cases, surgically correct the issues before birth.

Novel diagnostic and treatment options for patients facing cancer are increasingly available. For example, fluoroscopic illumination of sentinel lymph nodes and the increasing use of minimally invasive surgical approaches to treat early-stage and relapsed cancers are just two ways our gynecologic oncology team is promoting innovation, surgical quality and patient safety.

Genetic screening advances pioneered at our institution present an array of options for at-risk patients. Patients with family histories of ovarian, fallopian tube and uterine cancers may turn the unknown into opportunities to preemptively treat cancer even before a life-threatening diagnosis.

I hope you enjoy reading this issue of Johns Hopkins Gynecology, with its bird’s-eye view of the ways our team is pushing limits and broadening possibilities to provide the best possible care for our patients today and tomorrow.


Andrew Satin, M.D.
Director, Johns Hopkins Department of Gynecology and Obstetrics


For urgent referrals and consultations: 1-800-765-5447 (Hopkins Access Line)

Related Services